Grifols SA (GRFS)
9.67
+0.12
(+1.26%)
USD |
NASDAQ |
Nov 15, 11:26
Grifols Net Income (TTM): 216.85M for Sept. 30, 2024
Net Income (TTM) Chart
Historical Net Income (TTM) Data
Date | Value |
---|---|
September 30, 2024 | 216.85M |
June 30, 2024 | 201.62M |
December 31, 2023 | 206.17M |
September 30, 2023 | 171.86M |
June 30, 2023 | 203.26M |
December 31, 2022 | 326.60M |
September 30, 2022 | 462.65M |
June 30, 2022 | 576.18M |
June 30, 2021 | 792.69M |
March 31, 2021 | 662.82M |
December 31, 2020 | 711.93M |
September 30, 2020 | 776.91M |
June 30, 2020 | 615.97M |
March 31, 2020 | 774.67M |
December 31, 2019 | 698.91M |
September 30, 2019 | 621.95M |
June 30, 2019 | 643.77M |
March 31, 2019 | 659.61M |
December 31, 2018 | 705.87M |
September 30, 2018 | 831.38M |
June 30, 2018 | 838.69M |
March 31, 2018 | 787.35M |
December 31, 2017 | 753.91M |
September 30, 2017 | 632.31M |
June 30, 2017 | 609.48M |
Date | Value |
---|---|
March 31, 2017 | 608.45M |
December 31, 2016 | 603.88M |
September 30, 2016 | 596.35M |
June 30, 2016 | 593.96M |
March 31, 2016 | 583.68M |
December 31, 2015 | 590.49M |
September 30, 2015 | 611.61M |
June 30, 2015 | 607.18M |
March 31, 2015 | 602.65M |
December 31, 2014 | 623.40M |
September 30, 2014 | 566.34M |
June 30, 2014 | 526.72M |
March 31, 2014 | 504.17M |
December 31, 2013 | 458.58M |
September 30, 2013 | 428.67M |
June 30, 2013 | 396.84M |
March 31, 2013 | 361.64M |
December 31, 2012 | 330.04M |
September 30, 2012 | 261.84M |
June 30, 2012 | 216.68M |
March 31, 2012 | 111.26M |
December 31, 2011 | 68.75M |
September 30, 2011 | 85.08M |
June 30, 2011 | 89.95M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
171.86M
Minimum
Sep 2023
792.69M
Maximum
Jun 2021
493.27M
Average
576.18M
Median
Jun 2022
Net Income (TTM) Benchmarks
Cellectis SA | -84.48M |
Adaptimmune Therapeutics PLC | -72.50M |
Akari Therapeutics PLC | -16.12M |
Biodexa Pharmaceuticals PLC | -8.534M |
Verona Pharma PLC | -153.72M |